What Changed, and What Didnt In late 2023, the FDA moved 19 widely used peptides to its Category 2 list, effectively banning compounding pharmacies from preparing them
CJC without DAC for moderate pulsatile extension
Human skin studies have examined collagen production, skin elasticity, wrinkles, density, and topical photoaging outcomes [2]
search "BPC-157 systematic review" on PubMed) ACS Labs and WuXi AppTec analytical testing roundups on COA discrepancy rates in research-use-only peptide vendors PeptideLaws and Lumalex Law, trade coverage of Peptide Sciences voluntary shutdown, March 6, 2026 Orrick and Polsinelli law firm client alerts on FDA PCAC scheduling for BPC-157, TB-500, epitalon, and related peptides, 2026
BPC-157s role in collagen synthesis and cartilage repair could help manage symptoms and promote healing (8)